What we do
Harle Group is actively negotiating with life science companies in promoting their technologies to the Asian region. We currently represent the liquid biopsy technology of Biocept in the Philippine market. There are on going negotiations with other potential markets in the region.
The liquid biopsy provides greater understanding in the DNA mutations that prove the presence of cancer and sometimes the presence of mutations associated with susceptibility or resistance to specific cancer treatments.
For more info on liquid biopsy, go to www.biocept.com